期刊文献+

高血压患者强化管理与常规管理的比较研究 被引量:5

A Comparative Study Between Strengthening Management and Conventional Management in Patients With Hypertension
下载PDF
导出
摘要 目的:探讨高血压患者强化管理(MUST模式)与常规管理的比较研究。方法:建立高血压患者MUST管理模式,并与传统的常规管理模式比较,分析提高患者药物治疗、生活方式、血压监测、防治知识四个方面的依从性。210例高血压患者按照随机数字法分为两组,进入MUST强化管理模式的为干预组(n=105),采用常规管理模式的为对照组(n=105),均进行为期12个月的监测。分析比较两组血压控制和依从性的改进情况。结果:对药物治疗、生活方式、血压监测、防治知识四个分项依从性的分析,干预组上述四项指标依从性均得到显著改善,并且均分别优于对照组。干预组与对照组比较,收缩压和舒张压下降更多;干预组体质指数、胆固醇、甘油三酯、低密度脂蛋白胆固醇监测后与对照组同期比较均降低,差异均有统计学意义(P均〈0.05)。监测后干预组患者第12个月时完全从医比例为75.8%;干预组与对照组的血压控制率比较,始终较高,差异有统计学意义(X2=15.87~20.15,P〈0.05)。干预组在第3、6、9、12个月四个监测点的从医比例均分别高于对照组;而完全不从医比例每个监测点均显著低于对照组,差异均有统计学意义(X2=12.32~18.45,P〈0.05)结论:MUST模式强调家属作为监督者的身份参与高血压教育的重要性,可显著提高患者血压控制率和依从性。 Objective: To compare the differences between strengthening management (MUST) and conventional management in patients with hypertension. Methods: A total of 210 hypertension patients were randomly divided into 2 groups, Intervention group, the patients received strengthening management, in which the family member was involved for the education, and Control group, the patients received conventional management, n=105 in each group. The 4 compliances as medication, life style, blood pressure monitoring and prevention knowledge were compared between 2 groups and followed-up for 1 year. Results: The above 4 compliances in Intervention group were respectively and obviously improved than those in Control group. Compared with Control group, the Intervention group presented decreased systolic and diastolic blood pressure, decreased BMI, TC, TG and LDL-C, all P〈O.05. At the end of 12 months follow-up period, Intervention group had 75.8% of patients kept clinical consulting, and it also had better control rate of blood pressure (X 2=15.87-20.15, P〈O.05) than those in Control group. Intervention group also had higher clinical consulting rate at 3, 6, 9 and 12 months of examination time respectively ( X 2=12.32-18.45, P〈O.05). Conclusion: MUST model emphasizes the family member involved patient education, which may significantly improve the control rate of blood pressure and the related compliances in patients with hypertension.
出处 《中国循环杂志》 CSCD 北大核心 2013年第5期360-363,共4页 Chinese Circulation Journal
关键词 高血压 患者依从性 患者教育 家属 Hypertension Patient compliance Patient education Family member
  • 相关文献

参考文献16

  • 1Prado JC Jr , Mion D Jr. Adherence to medication: the importance of research in primary care. American Journal of Hypertension, 2010, 23: 109-109.
  • 2于文,韩静,孙迎俊,孟丽珍,甄桂兰,张栩.建立家属参与的糖尿病患者管理教育新模式[J].中华糖尿病杂志,2012,4(2):85-89. 被引量:28
  • 3刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6933
  • 4李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1779
  • 5Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens, 2011,29: 610-618.
  • 6Pittman DG, Tao Z, Chen W, et al. Antihypertensive medication adherence and subsequent healthcare utilization and costs, Am J Manag Care, 2010, 16: 568-576.
  • 7Criswell TJ , Weber, Carter BL, et al. Effect of self-efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy, 2010,30:432-441.
  • 8Ferrara AL, Pacioni D, Di Fronzo V, et al. Lifestyle educational program strongly increases compliance to non pharmacologic intervention in hypertensive patients: a 2-year follow-up study. J Clin Hypertens,2012,14:767-772.
  • 9Chowdhury EK, Owen A, Krum H, et al. Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals. J Hum Hypertens, 2013, 10: 1038.
  • 10Inqram RR, Ivanov LL. Examining the association of health literacy and health behaviors in African American older adults: does health literacy affect adherence to antihypertensive regimens?J Gerontol Nurs. 2013, 39: 22-32.

二级参考文献67

共引文献8636

同被引文献62

  • 1吴兆苏,霍勇,王文,赵连友,朱鼎良.中国高血压患者教育指南[J].中国医学前沿杂志(电子版),2014,6(3):78-109. 被引量:83
  • 2Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. Neurochero, 2000, 74: 34-41.
  • 3Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependenl mechanism. Regulatory Peptides, 2001, 99: 87-92.
  • 4Cheng X, Cheng XS, Pang CC. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur Pharmacol, 2003, 470: 171-175.
  • 5Lee DK, Saldivia VR, Nguyen T, et al. Modification of the terminal residue of apelin-13 antagonizes its hypotensive acti on. Endocrinology, 2005, 146:231- 236.
  • 6Barnes GD, Alam S, Carter G, et al. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure. Circ Heart Fail, 2013, 6 : 482-491.
  • 7American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care, 2011, 34(Suppl): S11-61.
  • 8Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289:2560-2572.
  • 9Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovsc Hematol Agents Med Chem, 2007, 5: 1-10.
  • 10Kleinz M J, Davenport AP. hnmunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial ceils. Regul Pept, 2004, 118: 119-125.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部